Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Delivery of anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis treatment
Lingyue Yan, Yafei Su, Isaac Hsia, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 36-47
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Biomedical applications of nanomaterials in the advancement of nucleic acid therapy: Mechanistic challenges, delivery strategies, and therapeutic applications
Krishna Yadav, Kantrol Kumar Sahu, Sucheta, et al.
International Journal of Biological Macromolecules (2023) Vol. 241, pp. 124582-124582
Open Access | Times Cited: 34
Emerging delivery approaches for targeted pulmonary fibrosis treatment
Rimpy Diwan, Himanshu Bhatt, Elfa Beaven, et al.
Advanced Drug Delivery Reviews (2023) Vol. 204, pp. 115147-115147
Open Access | Times Cited: 30
Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues
Panoraia I. Siafaka, Ece Özcan Bülbül, Αndroulla N. Miliotou, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105381-105381
Closed Access | Times Cited: 9
Engineering Ferroptosis Inhibitors as Inhalable Nanomedicines for the Highly Efficient Treatment of Idiopathic Pulmonary Fibrosis
Mengqin Guo, Tingting Peng, Chuanbin Wu, et al.
Bioengineering (2023) Vol. 10, Iss. 6, pp. 727-727
Open Access | Times Cited: 14
Krüppel-like factor 4 modulates the miR-101/COL10A1 axis to inhibit renal fibrosis after AKI by regulating epithelial–mesenchymal transition
Jingying Zhao, Xiuli Wang, Yubin Wu, et al.
Renal Failure (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 5
Pulmonary and lung-targeted drug delivery systems

Drug delivery (2025), pp. 43-70
Open Access
Intermittent hypoxia-reoxygenation-induced miRNAs inhibit expression of IRF and interferon genes but activate NF-κB and expression of pulmonary fibrosis markers in human small airway epithelial cells
S.-H. Chen, Cheng-Yu Jheng, Yu-Chun Lee, et al.
Life Sciences (2025), pp. 123569-123569
Closed Access
Nanodrug Delivery System for Precision Treatment of Pulmonary Fibrosis
Xianhao Yi, Xinru Zhang, Y. Guan, et al.
Precision medicine and engineering. (2025), pp. 100025-100025
Open Access
Investigational gene expression inhibitors for the treatment of idiopathic pulmonary fibrosis
Paolo Spagnolo, Roberto Tonelli, Marco Mura, et al.
Expert Opinion on Investigational Drugs (2025), pp. 1-20
Closed Access
Mechanisms and Therapeutic Potential of Myofibroblast Transformation in Pulmonary Fibrosis
Tianming Zhao, Yunchao Su
Deleted Journal (2025) Vol. 2, Iss. 1, pp. 10001-10001
Closed Access
Advances in locally administered nucleic acid therapeutics
Jie Shen, Xiangfeng Duan, Ting Xie, et al.
Bioactive Materials (2025) Vol. 49, pp. 218-254
Closed Access
Liposome-Encapsulated Therapies: Precision Medicine for Inflammatory Lung Disorders
Mohammad Arshad Javed Shaikh, K. L. Goyal, Muhammad Afzal, et al.
Nano TransMed (2025), pp. 100082-100082
Open Access
Creation and Application of Liposomal Form of MicroRNA for the Treatment of Neurodenegratative Diseases
Sergіy Shulga, H. S. Аndriiash, О. О. Тігунова, et al.
Cytology and Genetics (2025) Vol. 59, Iss. 2, pp. 197-205
Closed Access
Silica nanoparticles triggered epithelial ferroptosis via miR-21-5p/GCLM signaling to contribute to fibrogenesis in the lungs
Songqing Lv, Yan Li, Xueyan Li, et al.
Chemico-Biological Interactions (2024) Vol. 399, pp. 111121-111121
Closed Access | Times Cited: 2
Liposomal nano-carriers mediated targeting of liver disorders: mechanisms and applications
Mona M. AbouSamra
Journal of Liposome Research (2024) Vol. 34, Iss. 4, pp. 728-743
Closed Access | Times Cited: 2
MicroRNA‐146a‐5p protects retinal ganglion cells through reducing neuroinflammation in experimental glaucoma
Han Zhou, Rui‐Kang Yang, Qian Li, et al.
Glia (2024) Vol. 72, Iss. 11, pp. 2115-2141
Closed Access | Times Cited: 2
Emerging roles of non-coding RNAs in fibroblast to myofibroblast transition and fibrotic diseases
Xuewu Xing, Scott A. Rodeo
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
SPP1 promotes the polarization of M2 macrophages through the Jak2/Stat3 signaling pathway and accelerates the progression of idiopathic pulmonary fibrosis
Xuelian Yang, Ziqin Liu, Jiawei Zhou, et al.
International Journal of Molecular Medicine (2024) Vol. 54, Iss. 4
Open Access | Times Cited: 2
In Situ Bioorthogonal Repair of the Vascular Endothelium Glycocalyx to Treat Acute Lung Injury
Yao Wang, Rui Qu, Wenxuan Du, et al.
Small (2024)
Closed Access | Times Cited: 2
Emerging roles of noncoding RNAs in idiopathic pulmonary fibrosis
Haitao Wang, Kai Sun, Hao Peng, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Emerging Nanotechnology-based Therapeutics: A New Insight into Promising Drug Delivery System for Lung Cancer Therapy
Ravinder Verma, Lakshita Rao, Diksha Nagpal, et al.
Recent Patents on Nanotechnology (2023) Vol. 18, Iss. 4, pp. 395-414
Closed Access | Times Cited: 6
CELLULAR AND MOLECULAR GENETIC MECHANISMS OF LUNG FIBROSIS DEVELOPMENT AND THE ROLE OF VITAMIN D: REVIEW
Darya Enzel, Maxim Kriventsov, Tatiana Sataieva, et al.
(2024)
Open Access | Times Cited: 1
Nintedanib and miR-29b co-loaded lipoplexes in idiopathic pulmonary fibrosis: formulation, characterization, and in vitro evaluation
Ceren Duraloglu, İpek Baysal, Samiye Yabanoğlu‐Çiftçi, et al.
Drug Development and Industrial Pharmacy (2024) Vol. 50, Iss. 7, pp. 671-686
Closed Access | Times Cited: 1
Cellular and Molecular Genetic Mechanisms of Lung Fibrosis Development and the Role of Vitamin D: A Review
Darya Enzel, Maxim Kriventsov, Tatiana Sataieva, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8946-8946
Open Access | Times Cited: 1
Rynchopeterine inhibits the formation of hypertrophic scars by regulating the miR-21/HIF1AN axis
Wenbin Zhao, Jianzhou Ye, Xuesong Yang, et al.
Experimental Cell Research (2024) Vol. 440, Iss. 2, pp. 114114-114114
Closed Access
Page 1 - Next Page

Scroll to top